September 8 @ 13:45 – 14:45 CEST IS19: Metastatic EGFRm NSCLC: Adapting to Patients, Grounded in Evidence Room 04 Presented by AstraZeneca
September 8 @ 13:45 – 14:45 CEST IS18: A Decade of Progress: Advances in Immunotherapy for NSCLC Room 05 Presented by MSD
September 8 @ 13:45 – 14:45 CEST IS17: Targeted Therapies, Personalized Care: Patient-Centered Advances for the Treatment of NSCLC and SCLC Room 08 Presented by Boehringer Ingelheim International GmbH